What's happening
This bill creates a pilot program to test children with certain diagnoses for Lyme and tick-borne diseases and study misdiagnosis rates.
Why it matters
Addresses potential misdiagnosis. By specifically targeting children diagnosed with juvenile rheumatoid arthritis or other similar conditions, the pilot seeks to uncover cases where Lyme or tick-borne diseases may be incorrectly diagnosed as other illnesses, which can lead to more accurate and timely treatment for affected children.
Promotes evidence-based policy. The requirement for annual reports analyzing cost, efficiency, accuracy, and misdiagnosis rates will provide policymakers with concrete data. This could inform future statewide health protocols and resource allocation for Lyme and tick-borne disease prevention and diagnosis.
Enhances medical education. The bill mandates the development of updated graduate medical education curricula focused on identifying and diagnosing Lyme and tick-borne diseases in children, potentially leading to better-informed healthcare providers and improved patient outcomes over the long term.
Facilitates collaborative research. By allowing partnerships between qualified research institutions, not-for-profits, and academic organizations, the pilot encourages a multidisciplinary approach to understanding and addressing pediatric Lyme and tick-borne diseases, fostering innovation and shared best practices.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Test Kids for Tick Diseases
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to health
- Referred to health
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2148
2021-2022 Regular Sessions
IN SENATE
January 20, 2021
Introduced by Sens. SERINO, HELMING, O'MARA, RITCHIE, SAVINO, TEDISCO -read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to creating a pilot program for Lyme and tick-borne disease testing in children
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 206-b of the public health law, as added by chapter 260 of the laws of 1988, is amended to read as follows:
§ 206-b. Lyme and tick-borne disease. 1. Special requirements with respect to Lyme disease diagnosis. [1.] a. Within thirty days after the effective date of this section, the commissioner shall, in writing, order every physician practicing in Suffolk, Westchester and Nassau counties to review the medical records of any patient such physician treated during the period commencing January first, nineteen hundred seventy-five and ending on the date of such order wherein such physician made a diagnosis of juvenile rheumatoid arthritis and to review the circumstances of such diagnosis to reconsider whether such patient has suffered, or is suffering, from the complex, multi-system disorder caused by the bacterium Borrelia burgdorferi, which disease is transmitted by the Ixodes dammini tick and is commonly referred to as "Lyme disease". In any case where a hospital or other health care institution or provider has custody or control of the medical records for a patient so diagnosed, upon request such physician shall be entitled to review such medical records for purposes of complying with such order or the commissioner may order any such hospital or other health care institution or provider wherever situated within the state to review such records to reconsider a diagnosis of Lyme disease.
[2.] b. The commissioner, upon a showing that there is a reasonable basis to believe that the order provided for herein has not been complied with, shall be entitled to apply to a justice of the supreme
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07335-01-1
S. 2148 2
court for an order requiring any such physician to submit for the commissioner's consideration such records, charts or other pertinent data which will enable him to determine whether there has been full compliance with such order.
[3.] c. In any case where a review of such records indicates that a patient may have been, or is, suffering from Lyme disease, such physician shall, consistent with customary and acceptable medical standards, take such action he deems necessary to inform such patient or in the case of a minor, his or her parent or guardian of his findings, conduct additional tests, administer other necessary treatments or refer such patient to another physician for further diagnosis and/or treatment.
2. Pilot program for Lyme and tick-borne disease testing in children. a. Subject to appropriation, the commissioner is hereby authorized to establish a pilot program to test for Lyme and tick-borne diseases in children with qualifying diagnoses who present with similar symptoms. Such program, subject to the rules and regulations of the commissioner, shall provide for a test to rule out Lyme and tick-borne diseases in children with a qualifying diagnosis by an approved New York state qualified medical research institution or laboratory, at the request of a patient, medical provider, practitioner, hospital, or health care facility. The qualified medical research institution or laboratory shall be responsible for conducting serology testing, or other Lyme and tickborne disease tests approved by the commissioner, to determine the estimated rate of misdiagnosis and co-infections in children and for the development of continuing graduate medical education curriculum addressing the symptoms and diagnostic tools that can assist in accurately identifying and testing for Lyme and tick-borne diseases in children. The qualified medical research institution or laboratory may work with not-for-profits, professional associations, or academic institutions to develop the continuing graduate medical education curriculum.
b. For purposes of this subdivision, the following terms shall have the following meanings:
(i) "qualified medical research institution or laboratory" may include academic medical institutions, agencies, public or private organizations, public or private laboratories or any other institution or laboratory approved by the department that is conducting Lyme and tick-borne disease research, including but not limited to, testing for the presence of such infections;
(ii) "qualifying diagnoses" shall mean juvenile rheumatoid arthritis or any other common medical diagnosis that presents with similar symptoms to Lyme and tick-borne disease infections that the commissioner deems relevant; and
(iii) "children" shall mean all individuals under the age of eighteen who have a qualifying diagnosis.
c. The commissioner shall require the qualified medical research institution or laboratory under the pilot program to submit an annual report, which shall include data analyzing the cost, efficiency, and accuracy of tests provided under such program. The report shall also include estimated rates of misdiagnosis or co-infections of Lyme and tick-borne diseases of children with qualifying diagnoses. On or before December thirty-first, two thousand twenty-two, and annually thereafter, the commissioner shall submit such report to the governor, the temporary president of the senate and the speaker of the assembly.
d. Participation in the pilot program shall be voluntary and subject to participation guidelines established by the department. Nothing in this subdivision shall establish liability for any reasonable acts or
S. 2148 3
omissions on the part of a hospital, health care institution, or provider participating in the program.
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to creating a pilot program for Lyme and tick-borne disease testing in children
Purpose or general idea of bill
Amends the public health law, in relation to creating a pilot program for Lyme and tick-borne disease testing in children
Summary of provisions
Section 1 of the bill provides for a pilot program to be established by the Commissioner of Health for the purposes of providing testing to exclude Lyme and tick-borne diseases in children who have clinical diag- noses that have similar symptom presentation. The qualified medical institution or laboratory chosen for the pilot program shall provide for the exclusionary tests, as well as develop graduate medical education curriculum that can be used to instruct medical students on Lyme and tick-borne diseases in children.
Section 2 of the bill provides for the effective date.
Justification
The New York State Senate Task Force on Lyme and Tick-Borne Diseases, in conjunction with the Standing Committee on Health, convened a public hearing in August 2017 to examine the current issues surrounding this public health epidemic. There were countless stories presented about the debilitating impacts that these infections have had on patients, includ- ing physical, psychological, financial, and social consequences. While these stories largely centered on those adult patients who testified, experts noted that the highest rate of infections were in young children aged 5-7.
While New York has taken important steps in raising public awareness in schools about preventative ways of avoiding tick infections, it is important that we continue to target at-risk populations to ensure that they are treated early. Unfortunately, Lyme and tick-borne diseases are often misdiagnosed or unidentified as a co-infection in many cases. This legislation will allow the Commissioner of Health to establish a pilot program to allow health care practitioners and providers to voluntarily submit samples to exclude Lyme and tick-borne diseases from children who present with clinical diagnoses that have similar symptoms to these illnesses (e.g. juvenile arthritis).
The qualifying medical institution or laboratory that is chosen by the Commissioner of Health to provide the testing will be required to submit a report on the health outcomes to the Department of Health, as well as develop a graduate medical education curriculum to teach medical students about these illnesses. It is important that as we continue to fight the Lyme and tick-borne disease epidemic we do so with as much data and research-based evidence as possible. This legislation will provide for a way in which medical professionals can seek additional testing for in cases that can often present complex and ambiguous symp-
toms, and advance research to ultimately provide for better identifica- tion and treatment of these illnesses.
Prior legislative history
2019-20: S.1306 Referred to Health 2017-18: S.7169 Passed Senate/Referred to Health
Fiscal implications for state and local governments
Subject to Appropriation
Effective date
The bill shall take effect on the ninetieth day after it becomes a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.